18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume

James C. Reynolds; Roberto Maass-Moreno; Anish Thomas; Alexander Ling; Emerson B. Padiernos; Seth M. Steinberg; Raffit Hassan

doi:10.2967/jnumed.119.238733

Research ArticleOncology

¹⁸F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume

James C. Reynolds, Roberto Maass-Moreno, Anish Thomas, Alexander Ling, Emerson B. Padiernos, Seth M. Steinberg and Raffit Hassan

Journal of Nuclear Medicine November 2020, 61 (11) 1570-1575; DOI: https://doi.org/10.2967/jnumed.119.238733

James C. Reynolds

1Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roberto Maass-Moreno

1Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anish Thomas

2Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alexander Ling

1Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Emerson B. Padiernos

3Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Seth M. Steinberg

4Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raffit Hassan

3Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 61, Issue 11

November 1, 2020

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 18F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

¹⁸F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume

James C. Reynolds, Roberto Maass-Moreno, Anish Thomas, Alexander Ling, Emerson B. Padiernos, Seth M. Steinberg, Raffit Hassan

Journal of Nuclear Medicine Nov 2020, 61 (11) 1570-1575; DOI: 10.2967/jnumed.119.238733

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

¹⁸F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume

James C. Reynolds, Roberto Maass-Moreno, Anish Thomas, Alexander Ling, Emerson B. Padiernos, Seth M. Steinberg, Raffit Hassan

Journal of Nuclear Medicine Nov 2020, 61 (11) 1570-1575; DOI: 10.2967/jnumed.119.238733

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oncology

Comparative PSMA expression at early (1hour) vs late (2hour) in primary and secondary sites of involvement in prostate cancer.
Imaging spectrum of peritoneal carcinomatosis associated with various etiologies on 18F-FDG PET/CT
Diagnostic Role of 18F-FDG PET/CT in Urothelial carcinoma and its impact on management, and prognosis : A case based approach

Show more Oncology

Clinical

Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?

Show more Clinical

Keywords

18F-FDG PET
Pleural Mesothelioma
TLV
TLG

Main menu

User menu

Search

¹⁸F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis—The Central Role of Volume

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology

Clinical

Similar Articles

Keywords